James E. Strickler
Research Subjects
Research Interests
James E. Strickler has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Asim Malik
LifeSensors, Inc. Malvern Pennsylvania 19083
1 shared publication Craig A. Leach
Progenra, Inc., 277 Great Valley Parkway, Malvern, PA 19355, USA
1 shared publicationJian Wu
Progenra, Inc., 277 Great Valley Parkway, Malvern, PA 19355, USA
1 shared publication- Josh Spurrier
Department of Neurology, Yale University School of Medicine, New Haven, CT, USA
1 shared publication Li Liu
Lifesensors, Inc., Research and Development, Malvern, PA 19355, USA
1 shared publicationMark J. Engleka
LifeSensors, Inc. Malvern Pennsylvania 19083
1 shared publication
Latest Publications
- Open Access
- 17 September 2013
- Published by Wiley in Protein Science
- Vol. 22 (11) , 1466-1477
To fuse or not to fuse: What is your purpose?
Since the dawn of time, or at least the dawn of recombinant DNA technology (which for many of today's scientists is the same thing), investigators have been cloning and expressing heterologous proteins in a variety of different cells for a variety of different reasons. These range from cell biological studies looking at protein‐protein interactions, post‐translational modifications, and regulation, to laboratory‐scale production in support of biochemical, biophysical, and structural studies, to large scale production of potential biotherapeutics. In parallel, fusion‐tag technology has grown‐up to facilitate microscale purification (pull‐downs), protein visualization (epitope tags), enhanced expression and solubility (protein partners, e.g., GST, MBP, TRX, and SUMO), and generic purification (e.g., His‐tags, streptag, and FLAG™‐tag). Frequently, these latter two goals are combined in a single fusion partner. In this review, we examine the most commonly used fusion methodologies from the perspective of the ultimate use of the tagged protein. That is, what are the most commonly used fusion partners for pull‐downs, for structural studies, for production of active proteins, or for large‐scale purification? What are the advantages and limitations of each? This review is not meant to be exhaustive and the approach undoubtedly reflects the experiences and interests of the authors. For the sake of brevity, we have largely ignored epitope tags although they receive wide use in cell biology for immunopreciptation.
- 17 September 2013
- Published by Wiley in Protein Science
- Vol. 22 (11) , 1466-1477
Open AccessTo fuse or not to fuse: What is your purpose?
Since the dawn of time, or at least the dawn of recombinant DNA technology (which for many of today's scientists is the same thing), investigators have been cloning and expressing heterologous proteins in a variety of different cells for a variety of different reasons. These range from cell biological studies looking at protein‐protein interactions, post‐translational modifications, and regulation, to laboratory‐scale production in support of biochemical, biophysical, and structural studies, to large scale production of potential biotherapeutics. In parallel, fusion‐tag technology has grown‐up to facilitate microscale purification (pull‐downs), protein visualization (epitope tags), enhanced expression and solubility (protein partners, e.g., GST, MBP, TRX, and SUMO), and generic purification (e.g., His‐tags, streptag, and FLAG™‐tag). Frequently, these latter two goals are combined in a single fusion partner. In this review, we examine the most commonly used fusion methodologies from the perspective of the ultimate use of the tagged protein. That is, what are the most commonly used fusion partners for pull‐downs, for structural studies, for production of active proteins, or for large‐scale purification? What are the advantages and limitations of each? This review is not meant to be exhaustive and the approach undoubtedly reflects the experiences and interests of the authors. For the sake of brevity, we have largely ignored epitope tags although they receive wide use in cell biology for immunopreciptation.
- 13 June 2012
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1823 (11) , 2079-2086
Bioluminescence assay platform for selective and sensitive detection of Ub/Ubl proteases
- 13 June 2012
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1823 (11) , 2079-2086
Bioluminescence assay platform for selective and sensitive detection of Ub/Ubl proteases
- 1 November 2008
- Published by Elsevier in Protein Expression and Purification
- Vol. 62 (1) , 21-28
Enhanced protein expression in the baculovirus/insect cell system using engineered SUMO fusions
- 1 November 2008
- Published by Elsevier in Protein Expression and Purification
- Vol. 62 (1) , 21-28
Enhanced protein expression in the baculovirus/insect cell system using engineered SUMO fusions